Europe Insulin Delivery Devices Market Trends

An insulin pump is expected to register the highest CAGR of more than 3.8% in the market during the forecast period because of the increasing technological advancement and its preference over other traditional methods due to continuous insulin administration. An insulin pump is a device that delivers insulin continuously or automatically whenever required. The pump mimics the human pancreas. The insulin infusion pump works as an alternative to the traditional system of daily injections or an insulin pen.

According to the IDF 2021, the overall diabetes expenditure in Europe among the population aged 20-79 years was USD 156 billion, and it is expected to increase to USD 174 billion by 2040. According to other statistics from IDF, every year, 21,600 children are added to the type-1 diabetic population pool. These figures indicate that approximately 9% of the total healthcare expenditure is spent on diabetes in Europe. In Europe, a variety of insulin pumps are available. Traditional insulin pumps have an insulin reservoir and pumping mechanism attached to the body with tubing and an infusion set, and the other insulin patch pumps are worn directly on the body and have a reservoir, pumping mechanism, and infusion set inside a small case. Patch pumps are controlled wirelessly by a separate device that allows the programming of insulin delivery for meals from the patch. Most insurance companies in Europe cover insulin pump therapy with variable out-of-pocket expenses.

Insulin pump therapy is a well-established insulin administration method for people with type 1 diabetes (T1DM). Pumps are a validated, time-tested therapeutic option in T1DM at all ages, enabling near-physiological insulin delivery in situations where the pancreas does not produce insulin. There are even pump models with remote controls enabling parents of young children to either suspend or bolus insulin from a distance when the child is playing or eating.​ The insulin infusion pumps reduce the large swings in blood glucose levels, induce less pain, and deliver more accurately when compared to injections. The use of continuous subcutaneous insulin infusion and continuous glucose monitoring systems (CGMs) has improved patient care and quality of life. It is widely used in the ambulatory setting. Increasingly, this technology is also being used in the hospital setting. The technology combines glucose monitoring using a CGM with advanced algorithms in the insulin pump to predict low glucose and suspend insulin delivery.

Technological innovations in the insulin pump device market will likely drive the market during the forecast period. There are different ways to inject insulin into a patient’s body, using syringes, pens, pumps, and jet injectors, giving them various options for insulin delivery. The European insulin delivery devices market is segmented by type (insulin pumps, insulin syringes, cartridges in reusable pens, disposable pens, and jet injectors) and geography. The report offers the value (USD) and volume (unit) for the above segments.